GALE is the human cytosolic, NAD+-dependent UDP-galactose 4-epimerase (galactowaldenase; EC 5.1.3.2), which catalyses the fourth, recycling step of the Leloir pathway of galactose catabolism: the reversible interconversion of UDP-alpha-D-glucose and UDP-alpha-D-galactose. This activity regenerates the UDP-glucose consumed by galactose-1-phosphate uridylyltransferase (GALT) and supplies UDP-galactose for the biosynthesis of glycoproteins, glycolipids and other galactosylated glycoconjugates. The human enzyme is bifunctional and also interconverts UDP-N-acetyl-alpha-D-glucosamine and UDP-N-acetyl-alpha-D- galactosamine (EC 5.1.3.7), providing UDP-GalNAc for glycosylation; this second activity, absent in the bacterial ortholog, reflects an enlarged active-site sugar-binding pocket. The active enzyme is a homodimer with one tightly bound NAD+ per subunit; catalysis proceeds through transient oxidation of the sugar at C4, rotation, and stereospecific reduction, with Tyr157 acting as the active-site proton acceptor. Loss-of-function variants cause epimerase-deficiency galactosemia (galactosemia type III), which ranges from a benign peripheral form limited to circulating blood cells to a rare severe generalized form, and biallelic variants that predominantly impair the UDP-GalNAc/GlcNAc activity and N-glycosylation cause a syndromic macrothrombocytopenia.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0003978
UDP-glucose 4-epimerase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: UDP-glucose 4-epimerase (UDP-Glc <-> UDP-Gal, EC 5.1.3.2) is the defining, phylogenetically conserved molecular function of GALE across the panther family. This is the core molecular function and is independently supported by direct biochemical assay of the human enzyme.
Reason: Core molecular function. The IBA is consistent with direct experimental characterization of purified human GALE catalysing UDP-glucose/UDP-galactose interconversion, and with the crystal structure of the enzyme in complex with NAD and UDP-glucose.
Supporting Evidence:
PMID:16302980
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion of UDP-glucose and UDP-galactose.
|
|
GO:0033499
beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: GALE catalyses the recycling (fourth) step of the Leloir pathway, regenerating UDP-glucose and supplying UDP-galactose, so that dietary galactose is ultimately routed to glycolytic intermediates. This is the most specific and informative biological-process term for the gene and is the primary process annotation.
Reason: Accurately captures GALE's role in the Leloir pathway of galactose catabolism. Supported by UniProt pathway annotation and by the enzyme's established biochemistry.
Supporting Evidence:
PMID:16302980
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion of UDP-glucose and UDP-galactose.
|
|
GO:0005829
cytosol
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: GALE is a soluble cytosolic enzyme; it has no signal peptide, transmembrane region, or organellar targeting sequence, and Reactome models the catalytic step as occurring in the cytosol.
Reason: Consistent with the cytosolic localization documented by Reactome and with the absence of any targeting features in the UniProt sequence.
Supporting Evidence:
Reactome:R-HSA-70369
Cytosolic UDP-galactose 4-epimerase catalyzes the interconversion of UDP-D-galactose and UDP-D-glucose
|
|
GO:0003974
UDP-N-acetylglucosamine 4-epimerase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: The human enzyme is bifunctional and also catalyses the reversible epimerization of UDP-N-acetyl-D-glucosamine and UDP-N-acetyl-D-galactosamine (EC 5.1.3.7, RHEA:20517), supplying UDP-GalNAc for glycoconjugate synthesis. This second activity is experimentally established for human GALE (unlike the E. coli ortholog) and is central to the N-glycosylation defect seen in GALE-related thrombocytopenia.
Reason: The EC 5.1.3.7 / RHEA:20517 mapping is a correct, experimentally corroborated secondary catalytic activity of the human enzyme, not an over-broad IEA. UniProt documents both catalytic activities (EC 5.1.3.2 and EC 5.1.3.7) on the basis of direct assay, and structural studies show the enlarged active site accommodates the N-acetyl group. No verbatim supporting quote is attached here because the cached publications and Reactome reaction document only the UDP-Glc/UDP-Gal (EC 5.1.3.2) activity; the N-acetylhexosamine activity rests on the UniProt catalytic-activity annotation (RHEA:20517).
|
|
GO:0003978
UDP-glucose 4-epimerase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic assertion of the core UDP-glucose 4-epimerase activity from the EC 5.1.3.2 / RHEA:22168 mapping and InterPro family membership. Redundant with, and corroborated by, the IBA and IDA annotations to the same term.
Reason: Correct EC/RHEA/InterPro-based mapping of the core molecular function; consistent with direct experimental evidence.
Supporting Evidence:
PMID:16302980
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion of UDP-glucose and UDP-galactose.
|
|
GO:0006012
galactose metabolic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Involvement in galactose metabolism is correct but is a broad parent of the more specific Leloir-pathway catabolic term (GO:0033499). Retained as a valid, if general, process annotation.
Reason: Accurate at the general level (galactose metabolic process); the more specific GO:0033499 and GO:0019388 annotations provide the informative process terms. No reason to remove a correct broader parent.
Supporting Evidence:
PMID:16302980
the genetic disease, type III galactosemia
|
|
GO:0042802
identical protein binding
|
IPI
PMID:16189514 Towards a proteome-scale map of the human protein-protein in... |
MARK AS OVER ANNOTATED |
Summary: Self-interaction (Q14376-Q14376) detected in a large-scale human protein interactome map. This reflects the enzyme's known homodimeric state but is a low-information molecular-function term.
Reason: The self-interaction is real and consistent with the established homodimer, but "identical protein binding" is an uninformative term relative to the more specific GO:0042803 protein homodimerization activity already annotated for this gene, and it is repeated five times from high-throughput interactome screens. Kept but flagged as over-annotated; the homodimer is best represented by GO:0042803.
Supporting Evidence:
PMID:16189514
Towards a proteome-scale map of the human protein-protein interaction network.
|
|
GO:0042802
identical protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
MARK AS OVER ANNOTATED |
Summary: Self-interaction reported in a proteome-scale human interactome map, consistent with the GALE homodimer. Low-information duplicate of the same identical-protein-binding assertion.
Reason: Same rationale as the other identical-protein-binding annotations: real but uninformative relative to GO:0042803 protein homodimerization activity; one of five duplicate high-throughput self-interaction annotations.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network.
|
|
GO:0042802
identical protein binding
|
IPI
PMID:25502805 A massively parallel pipeline to clone DNA variants and exam... |
MARK AS OVER ANNOTATED |
Summary: Self-interaction reported in a large-scale variant/interaction phenotyping pipeline, consistent with the GALE homodimer.
Reason: Real self-interaction but uninformative relative to GO:0042803; duplicate high-throughput identical-protein-binding annotation.
Supporting Evidence:
PMID:25502805
A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations.
|
|
GO:0042802
identical protein binding
|
IPI
PMID:31515488 Extensive disruption of protein interactions by genetic vari... |
MARK AS OVER ANNOTATED |
Summary: Self-interaction reported in a systematic study of interaction disruption by human genetic variants, consistent with the GALE homodimer.
Reason: Real self-interaction but uninformative relative to GO:0042803; duplicate high-throughput identical-protein-binding annotation.
Supporting Evidence:
PMID:31515488
Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.
|
|
GO:0042802
identical protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Self-interaction reported in the HuRI reference map of the human binary protein interactome, consistent with the GALE homodimer.
Reason: Real self-interaction but uninformative relative to GO:0042803; duplicate high-throughput identical-protein-binding annotation.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome.
|
|
GO:0033499
beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Electronic (Ensembl Compara ortholog-based) transfer of the Leloir-pathway galactose catabolic process, transferred from the mouse ortholog (Q8R059). Consistent with the IBA annotation to the same term and with GALE's established function.
Reason: Correct process assignment; the ortholog-based inference agrees with the manual IBA annotation and with the enzyme's biochemistry. No over-propagation concern for this well-conserved Leloir enzyme.
Supporting Evidence:
PMID:16302980
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion of UDP-glucose and UDP-galactose.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-5610036 |
ACCEPT |
Summary: Reactome traceable-author-statement localizing GALE to the cytosol, in the context of defective GALE failing to epimerise UDP-Gal to UDP-Glc. Consistent with the other cytosol annotations.
Reason: GALE is a soluble cytosolic enzyme; localization is well established. Duplicate of the other cytosol annotations, which is acceptable.
Supporting Evidence:
Reactome:R-HSA-70369
Cytosolic UDP-galactose 4-epimerase catalyzes the interconversion of UDP-D-galactose and UDP-D-glucose
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-70369 |
ACCEPT |
Summary: Reactome traceable-author-statement placing the GALE:NAD+ dimer epimerization reaction in the cytosol. Directly supports the cytosolic localization of the active enzyme.
Reason: Well-supported cytosolic localization of the catalytically active homodimer.
Supporting Evidence:
Reactome:R-HSA-70369
Cytosolic UDP-galactose 4-epimerase catalyzes the interconversion of UDP-D-galactose and UDP-D-glucose
|
|
GO:0003978
UDP-glucose 4-epimerase activity
|
IDA
PMID:16302980 Functional analysis of disease-causing mutations in human UD... |
ACCEPT |
Summary: Direct assay of recombinant purified human GALE established UDP-glucose/UDP-galactose epimerase activity and its kinetic parameters, including the effects of disease-causing mutations on turnover and specificity. This is the strongest direct evidence for the core molecular function.
Reason: Experimental (IDA) confirmation of the core catalytic activity in the human enzyme.
Supporting Evidence:
PMID:16302980
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion of UDP-glucose and UDP-galactose.
|
|
GO:0019388
galactose catabolic process
|
IDA
PMID:16302980 Functional analysis of disease-causing mutations in human UD... |
ACCEPT |
Summary: GALE's epimerase activity is required for galactose catabolism, and impairment causes type III galactosemia; the direct functional characterization links the enzyme to galactose breakdown. GO:0033499 is the more specific Leloir-pathway child, but this general catabolic term is correct.
Reason: Accurate process assignment supported by direct functional/disease evidence. Retained alongside the more specific GO:0033499.
Supporting Evidence:
PMID:16302980
Point mutations in this enzyme are associated with the genetic disease, type III galactosemia
|
|
GO:0042803
protein homodimerization activity
|
IPI
PMID:16302980 Functional analysis of disease-causing mutations in human UD... |
ACCEPT |
Summary: The active enzyme is a homodimer; protein-protein crosslinking of wild-type and mutant GALE demonstrated homodimer formation, and the crystal structure is dimeric. This is the informative representation of GALE's self-association.
Reason: Well-supported homodimerization, established both biochemically (crosslinking) and structurally. Preferred over the bare identical-protein-binding annotations for representing the same underlying self-association.
Supporting Evidence:
PMID:16302980
Protein-protein crosslinking suggests that none of the mutants are impaired in homodimer formation.
|
|
GO:0051287
NAD binding
|
IDA
PMID:10801319 Crystallographic evidence for Tyr 157 functioning as the act... |
NEW |
Summary: GALE binds NAD+ as a tightly bound cofactor, one molecule per subunit, essential for the transient oxidation/reduction chemistry of epimerization. The crystal structure resolves the bound NAD, and UniProt annotates multiple NAD(+)-binding residues.
Reason: NAD binding is a well-established, structurally and biochemically documented molecular function of GALE that is missing from the existing annotation set. Added as a new annotation for the enzyme's cofactor-binding role.
Supporting Evidence:
PMID:10801319
structures of human epimerase in the resting state (i.e., with bound NAD(+))
|
Q: To what extent does the UDP-GalNAc/GlcNAc 4-epimerase activity of GALE, versus its UDP-Gal/Glc activity, account for the distinct clinical phenotypes (galactosemia versus syndromic macrothrombocytopenia) seen with different GALE variants?
Experiment: Systematically measure both UDP-Gal/Glc (EC 5.1.3.2) and UDP-GalNAc/GlcNAc (EC 5.1.3.7) epimerase activities for a panel of galactosemia- and thrombocytopenia-associated GALE variants, and correlate the differential loss of each activity with glycosylation status and clinical presentation.
Type: enzyme kinetics and glycomics
UniProtKB: Q14376 (GALE_HUMAN), HGNC:4116, 348 aa. Gene on chromosome 1.
GALE is the cytosolic, NAD+-dependent UDP-galactose 4-epimerase (galactowaldenase)
catalysing the fourth (recycling) step of the Leloir pathway of galactose
catabolism. It is a bifunctional enzyme:
UniProt FUNCTION: "Catalyzes two distinct but analogous reactions: the reversible
epimerization of UDP-glucose to UDP-galactose and the reversible epimerization of
UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The reaction with UDP-Gal plays a
critical role in the Leloir pathway of galactose catabolism ... Both UDP-sugar
interconversions are important in the synthesis of glycoproteins and glycolipids."
[ECO:0000269|PubMed:22654673].
Confirms GALE deficiency = one of three Leloir-pathway galactosemia enzymes; phenotype
"ranges from benign peripheral form to severe generalized form resembling classic
galactosemia" (MONDO:0009257 galactose epimerase deficiency).
Existing GOA (18 lines):
- GO:0003978 UDP-glucose 4-epimerase activity: IBA (GO_REF:0000033), IEA
(GO_REF:0000120, EC 5.1.3.2/RHEA:22168), IDA (PMID:16302980). CORE MF. ACCEPT all.
- GO:0003974 UDP-N-acetylglucosamine 4-epimerase activity: IEA (GO_REF:0000120, EC
5.1.3.7/RHEA:20517). This is the second, human-specific bifunctional activity, well
supported by UniProt/PMID:22654673/PMID:11279032. ACCEPT (core secondary MF).
- GO:0006012 galactose metabolic process (IEA), GO:0033499 galactose catabolic process
via UDP-galactose Leloir pathway (IBA + IEA GO_REF:0000107), GO:0019388 galactose
catabolic process (IDA PMID:16302980): all BP for galactose catabolism/Leloir; ACCEPT.
GO:0033499 is the most specific/informative (Leloir).
- GO:0005829 cytosol: IBA + 2x TAS (Reactome). ACCEPT (cytosolic enzyme).
- GO:0042803 protein homodimerization activity: IPI PMID:16302980. ACCEPT — active enzyme
is a homodimer (structurally & biochemically established). More informative than bare
identical protein binding.
- GO:0042802 identical protein binding: 5x IPI from high-throughput interactome maps
(IntAct; Q14376-Q14376 self-interaction). Not wrong (reflects the homodimer) but a
low-information molecular-function term duplicated 5x from HT screens. MARK_AS_OVER_ANNOTATED;
the homodimer is better captured by GO:0042803.
Missing but supported (candidate NEW): NAD binding (GO:0051287) — tightly bound cofactor,
extensive structural evidence (PMID:10801319, PMID:22654673, UniProt BINDING features).
id: Q14376
gene_symbol: GALE
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
GALE is the human cytosolic, NAD+-dependent UDP-galactose 4-epimerase
(galactowaldenase; EC 5.1.3.2), which catalyses the fourth, recycling step of
the Leloir pathway of galactose catabolism: the reversible interconversion of
UDP-alpha-D-glucose and UDP-alpha-D-galactose. This activity regenerates the
UDP-glucose consumed by galactose-1-phosphate uridylyltransferase (GALT) and
supplies UDP-galactose for the biosynthesis of glycoproteins, glycolipids and
other galactosylated glycoconjugates. The human enzyme is bifunctional and also
interconverts UDP-N-acetyl-alpha-D-glucosamine and UDP-N-acetyl-alpha-D-
galactosamine (EC 5.1.3.7), providing UDP-GalNAc for glycosylation; this second
activity, absent in the bacterial ortholog, reflects an enlarged active-site
sugar-binding pocket. The active enzyme is a homodimer with one tightly bound
NAD+ per subunit; catalysis proceeds through transient oxidation of the sugar at
C4, rotation, and stereospecific reduction, with Tyr157 acting as the active-site
proton acceptor. Loss-of-function variants cause epimerase-deficiency galactosemia
(galactosemia type III), which ranges from a benign peripheral form limited to
circulating blood cells to a rare severe generalized form, and biallelic variants
that predominantly impair the UDP-GalNAc/GlcNAc activity and N-glycosylation cause
a syndromic macrothrombocytopenia.
alternative_products:
- name: '1'
id: Q14376-1
- name: '2'
id: Q14376-2
sequence_note: VSP_056822
existing_annotations:
- term:
id: GO:0003978
label: UDP-glucose 4-epimerase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
UDP-glucose 4-epimerase (UDP-Glc <-> UDP-Gal, EC 5.1.3.2) is the defining,
phylogenetically conserved molecular function of GALE across the panther
family. This is the core molecular function and is independently supported by
direct biochemical assay of the human enzyme.
action: ACCEPT
reason: >-
Core molecular function. The IBA is consistent with direct experimental
characterization of purified human GALE catalysing UDP-glucose/UDP-galactose
interconversion, and with the crystal structure of the enzyme in complex with
NAD and UDP-glucose.
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion
of UDP-glucose and UDP-galactose.
- term:
id: GO:0033499
label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
GALE catalyses the recycling (fourth) step of the Leloir pathway, regenerating
UDP-glucose and supplying UDP-galactose, so that dietary galactose is ultimately
routed to glycolytic intermediates. This is the most specific and informative
biological-process term for the gene and is the primary process annotation.
action: ACCEPT
reason: >-
Accurately captures GALE's role in the Leloir pathway of galactose catabolism.
Supported by UniProt pathway annotation and by the enzyme's established
biochemistry.
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion
of UDP-glucose and UDP-galactose.
- term:
id: GO:0005829
label: cytosol
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
GALE is a soluble cytosolic enzyme; it has no signal peptide, transmembrane
region, or organellar targeting sequence, and Reactome models the catalytic
step as occurring in the cytosol.
action: ACCEPT
reason: >-
Consistent with the cytosolic localization documented by Reactome and with the
absence of any targeting features in the UniProt sequence.
supported_by:
- reference_id: Reactome:R-HSA-70369
supporting_text: >-
Cytosolic UDP-galactose 4-epimerase catalyzes the interconversion of
UDP-D-galactose and UDP-D-glucose
- term:
id: GO:0003974
label: UDP-N-acetylglucosamine 4-epimerase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
The human enzyme is bifunctional and also catalyses the reversible epimerization
of UDP-N-acetyl-D-glucosamine and UDP-N-acetyl-D-galactosamine (EC 5.1.3.7,
RHEA:20517), supplying UDP-GalNAc for glycoconjugate synthesis. This second
activity is experimentally established for human GALE (unlike the E. coli ortholog)
and is central to the N-glycosylation defect seen in GALE-related thrombocytopenia.
action: ACCEPT
reason: >-
The EC 5.1.3.7 / RHEA:20517 mapping is a correct, experimentally corroborated secondary
catalytic activity of the human enzyme, not an over-broad IEA. UniProt documents both
catalytic activities (EC 5.1.3.2 and EC 5.1.3.7) on the basis of direct assay, and
structural studies show the enlarged active site accommodates the N-acetyl group. No
verbatim supporting quote is attached here because the cached publications and Reactome
reaction document only the UDP-Glc/UDP-Gal (EC 5.1.3.2) activity; the N-acetylhexosamine
activity rests on the UniProt catalytic-activity annotation (RHEA:20517).
- term:
id: GO:0003978
label: UDP-glucose 4-epimerase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic assertion of the core UDP-glucose 4-epimerase activity from the EC
5.1.3.2 / RHEA:22168 mapping and InterPro family membership. Redundant with, and
corroborated by, the IBA and IDA annotations to the same term.
action: ACCEPT
reason: >-
Correct EC/RHEA/InterPro-based mapping of the core molecular function; consistent
with direct experimental evidence.
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion
of UDP-glucose and UDP-galactose.
- term:
id: GO:0006012
label: galactose metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
Involvement in galactose metabolism is correct but is a broad parent of the more
specific Leloir-pathway catabolic term (GO:0033499). Retained as a valid, if
general, process annotation.
action: ACCEPT
reason: >-
Accurate at the general level (galactose metabolic process); the more specific
GO:0033499 and GO:0019388 annotations provide the informative process terms. No
reason to remove a correct broader parent.
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
the genetic disease, type III galactosemia
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:16189514
qualifier: enables
review:
summary: >-
Self-interaction (Q14376-Q14376) detected in a large-scale human protein
interactome map. This reflects the enzyme's known homodimeric state but is a
low-information molecular-function term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The self-interaction is real and consistent with the established homodimer, but
"identical protein binding" is an uninformative term relative to the more specific
GO:0042803 protein homodimerization activity already annotated for this gene, and it
is repeated five times from high-throughput interactome screens. Kept but flagged as
over-annotated; the homodimer is best represented by GO:0042803.
supported_by:
- reference_id: PMID:16189514
supporting_text: >-
Towards a proteome-scale map of the human protein-protein interaction network.
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
qualifier: enables
review:
summary: >-
Self-interaction reported in a proteome-scale human interactome map, consistent with
the GALE homodimer. Low-information duplicate of the same identical-protein-binding
assertion.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Same rationale as the other identical-protein-binding annotations: real but
uninformative relative to GO:0042803 protein homodimerization activity; one of five
duplicate high-throughput self-interaction annotations.
supported_by:
- reference_id: PMID:25416956
supporting_text: >-
A proteome-scale map of the human interactome network.
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:25502805
qualifier: enables
review:
summary: >-
Self-interaction reported in a large-scale variant/interaction phenotyping pipeline,
consistent with the GALE homodimer.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Real self-interaction but uninformative relative to GO:0042803; duplicate
high-throughput identical-protein-binding annotation.
supported_by:
- reference_id: PMID:25502805
supporting_text: >-
A massively parallel pipeline to clone DNA variants and examine molecular
phenotypes of human disease mutations.
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:31515488
qualifier: enables
review:
summary: >-
Self-interaction reported in a systematic study of interaction disruption by human
genetic variants, consistent with the GALE homodimer.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Real self-interaction but uninformative relative to GO:0042803; duplicate
high-throughput identical-protein-binding annotation.
supported_by:
- reference_id: PMID:31515488
supporting_text: >-
Extensive disruption of protein interactions by genetic variants across the
allele frequency spectrum in human populations.
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Self-interaction reported in the HuRI reference map of the human binary protein
interactome, consistent with the GALE homodimer.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Real self-interaction but uninformative relative to GO:0042803; duplicate
high-throughput identical-protein-binding annotation.
supported_by:
- reference_id: PMID:32296183
supporting_text: >-
A reference map of the human binary protein interactome.
- term:
id: GO:0033499
label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Electronic (Ensembl Compara ortholog-based) transfer of the Leloir-pathway galactose
catabolic process, transferred from the mouse ortholog (Q8R059). Consistent with the
IBA annotation to the same term and with GALE's established function.
action: ACCEPT
reason: >-
Correct process assignment; the ortholog-based inference agrees with the manual IBA
annotation and with the enzyme's biochemistry. No over-propagation concern for this
well-conserved Leloir enzyme.
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion
of UDP-glucose and UDP-galactose.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5610036
qualifier: located_in
review:
summary: >-
Reactome traceable-author-statement localizing GALE to the cytosol, in the context of
defective GALE failing to epimerise UDP-Gal to UDP-Glc. Consistent with the other
cytosol annotations.
action: ACCEPT
reason: >-
GALE is a soluble cytosolic enzyme; localization is well established. Duplicate of the
other cytosol annotations, which is acceptable.
supported_by:
- reference_id: Reactome:R-HSA-70369
supporting_text: >-
Cytosolic UDP-galactose 4-epimerase catalyzes the interconversion of
UDP-D-galactose and UDP-D-glucose
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-70369
qualifier: located_in
review:
summary: >-
Reactome traceable-author-statement placing the GALE:NAD+ dimer epimerization reaction
in the cytosol. Directly supports the cytosolic localization of the active enzyme.
action: ACCEPT
reason: >-
Well-supported cytosolic localization of the catalytically active homodimer.
supported_by:
- reference_id: Reactome:R-HSA-70369
supporting_text: >-
Cytosolic UDP-galactose 4-epimerase catalyzes the interconversion of
UDP-D-galactose and UDP-D-glucose
- term:
id: GO:0003978
label: UDP-glucose 4-epimerase activity
evidence_type: IDA
original_reference_id: PMID:16302980
qualifier: enables
review:
summary: >-
Direct assay of recombinant purified human GALE established UDP-glucose/UDP-galactose
epimerase activity and its kinetic parameters, including the effects of disease-causing
mutations on turnover and specificity. This is the strongest direct evidence for the
core molecular function.
action: ACCEPT
reason: >-
Experimental (IDA) confirmation of the core catalytic activity in the human enzyme.
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion
of UDP-glucose and UDP-galactose.
- term:
id: GO:0019388
label: galactose catabolic process
evidence_type: IDA
original_reference_id: PMID:16302980
qualifier: involved_in
review:
summary: >-
GALE's epimerase activity is required for galactose catabolism, and impairment causes
type III galactosemia; the direct functional characterization links the enzyme to
galactose breakdown. GO:0033499 is the more specific Leloir-pathway child, but this
general catabolic term is correct.
action: ACCEPT
reason: >-
Accurate process assignment supported by direct functional/disease evidence. Retained
alongside the more specific GO:0033499.
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
Point mutations in this enzyme are associated with the genetic disease, type III
galactosemia
- term:
id: GO:0042803
label: protein homodimerization activity
evidence_type: IPI
original_reference_id: PMID:16302980
qualifier: enables
review:
summary: >-
The active enzyme is a homodimer; protein-protein crosslinking of wild-type and mutant
GALE demonstrated homodimer formation, and the crystal structure is dimeric. This is
the informative representation of GALE's self-association.
action: ACCEPT
reason: >-
Well-supported homodimerization, established both biochemically (crosslinking) and
structurally. Preferred over the bare identical-protein-binding annotations for
representing the same underlying self-association.
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
Protein-protein crosslinking suggests that none of the mutants are impaired in
homodimer formation.
- term:
id: GO:0051287
label: NAD binding
evidence_type: IDA
original_reference_id: PMID:10801319
qualifier: enables
review:
summary: >-
GALE binds NAD+ as a tightly bound cofactor, one molecule per subunit, essential for the
transient oxidation/reduction chemistry of epimerization. The crystal structure resolves
the bound NAD, and UniProt annotates multiple NAD(+)-binding residues.
action: NEW
reason: >-
NAD binding is a well-established, structurally and biochemically documented molecular
function of GALE that is missing from the existing annotation set. Added as a new
annotation for the enzyme's cofactor-binding role.
supported_by:
- reference_id: PMID:10801319
supporting_text: >-
structures of human epimerase in the resting state (i.e., with bound NAD(+))
core_functions:
- description: >-
NAD+-dependent UDP-glucose 4-epimerase catalysing the reversible interconversion of
UDP-glucose and UDP-galactose, the recycling step of the Leloir pathway of galactose
catabolism, acting as a cytosolic homodimer.
molecular_function:
id: GO:0003978
label: UDP-glucose 4-epimerase activity
directly_involved_in:
- id: GO:0033499
label: galactose catabolic process via UDP-galactose, Leloir pathway
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:16302980
supporting_text: >-
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion of
UDP-glucose and UDP-galactose.
- description: >-
Bifunctional UDP-N-acetylglucosamine 4-epimerase activity interconverting UDP-GlcNAc and
UDP-GalNAc, supplying UDP-GalNAc for glycoprotein and glycolipid biosynthesis; a
cytosolic activity specific to the human enzyme.
molecular_function:
id: GO:0003974
label: UDP-N-acetylglucosamine 4-epimerase activity
locations:
- id: GO:0005829
label: cytosol
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:16189514
title: Towards a proteome-scale map of the human protein-protein interaction network.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput interactome screen; source of the Q14376-Q14376 self-interaction
(identical protein binding) annotation. Consistent with the known homodimer but does
not directly inform GALE's catalytic function.
- id: PMID:16302980
title: Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase.
findings:
- statement: >-
Human GALE (EC 5.1.3.2) catalyses the interconversion of UDP-glucose and UDP-galactose;
disease-causing mutations reduce catalytic efficiency and increase proteolytic
susceptibility, causing type III galactosemia.
supporting_text: >-
UDP-galactose 4-epimerase (GALE, EC 5.1.3.2) catalyses the interconversion of
UDP-glucose and UDP-galactose.
- statement: GALE forms a homodimer; disease mutations do not impair homodimer formation.
supporting_text: >-
Protein-protein crosslinking suggests that none of the mutants are impaired in
homodimer formation.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Direct enzymatic characterization of recombinant human GALE and disease variants;
supports the core epimerase activity, homodimerization, and role in galactose
catabolism / type III galactosemia.
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput interactome map; source of a GALE self-interaction annotation.
- id: PMID:25502805
title: A massively parallel pipeline to clone DNA variants and examine molecular
phenotypes of human disease mutations.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale variant/interaction phenotyping pipeline; source of a GALE self-interaction
annotation.
- id: PMID:31515488
title: Extensive disruption of protein interactions by genetic variants across the
allele frequency spectrum in human populations.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Systematic study of variant-driven interaction disruption; source of a GALE
self-interaction annotation.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
HuRI reference binary interactome; source of a GALE self-interaction annotation
consistent with the homodimer.
- id: Reactome:R-HSA-5610036
title: Defective GALE does not epimerise UDP-Gal to UDP-Glc
findings: []
- id: Reactome:R-HSA-70369
title: GALE:NAD+ dimer reversibly epimerises UDP-Gal to UDP-Glc
findings:
- statement: >-
Cytosolic GALE catalyses the interconversion of UDP-D-galactose and UDP-D-glucose; the
active enzyme is a homodimer with one molecule of bound NAD+ per monomer.
supporting_text: >-
The active form of the enzyme is a homodimer with one molecule of bound NAD+ per
monomer
- id: PMID:10801319
title: Crystallographic evidence for Tyr 157 functioning as the active site base in
human UDP-galactose 4-epimerase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Crystal structure of human GALE in complex with NAD and UDP-glucose; establishes the
bound NAD+ cofactor, the homodimer, and Tyr157 as the active-site proton acceptor.
proposed_new_terms: []
suggested_questions:
- question: >-
To what extent does the UDP-GalNAc/GlcNAc 4-epimerase activity of GALE, versus its
UDP-Gal/Glc activity, account for the distinct clinical phenotypes (galactosemia versus
syndromic macrothrombocytopenia) seen with different GALE variants?
suggested_experiments:
- description: >-
Systematically measure both UDP-Gal/Glc (EC 5.1.3.2) and UDP-GalNAc/GlcNAc (EC 5.1.3.7)
epimerase activities for a panel of galactosemia- and thrombocytopenia-associated GALE
variants, and correlate the differential loss of each activity with glycosylation status
and clinical presentation.
experiment_type: enzyme kinetics and glycomics